Skip to content

Dr. Evelien Heireman

Active
Private limited companyfounded 2025active for 1 yearCiamberlanidreef(BEV) 22, 9120 Beveren-Kruibeke-Zwijndrecht, BelgiumKBO/BCE: BE 1023.138.380
Summary

Dr. Evelien Heireman has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2026 annual accounts show equity of €81,135 and a net result of €53,413. Its solvency ranks better than 60% of 265 sector peers (NACE 86, financial year 2026). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Activity
Specialist medical practice
NACE 86220
1 site
Size
€98,168total assets 2026
Equity
€81,135
Profit
€53,413
Turnover not published (micro format)
Financial health
98 Excellent Checked score 2026
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
Accounts 139 days early
Why 98lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 4.24, cash €62,986Equity €81,135 (82.6% of total assets)Size: total assets €98,168Show the evidence

Checked score

Score 2026
98 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 85% of its sector peers (NACE 86, micro)
Financial strength · tick = 2025
Strong
Solvency 100+7
equity 82.6% of total assets
Liquidity 95+35
short-term debt 17.4% · cash 64.2%
Profitability 100=
return on assets 54.4%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,109 companies, NACE 86, micro)
Last 24 months 06-2026: 0.3% 07-2026: 0.3%● unchanged vs 06-2026 08-2026: 0.3%● unchanged vs 07-2026 09-2026: 0.3%● unchanged vs 08-2026highest value 10-2026: < 0.1%▼ -0.3 percentage points vs 09-2026lowest value
Credit of up to €7,000 on 30-day terms, only on tighter conditions: young company (under 3 years) without a track record
Liquidity ample (current ratio 4.24, compared with 0.86 in 2025, above the usual 1.5; short-term debt: 17.4% and cash: 64.2% of total assets), and 17.4% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 82% on solvency, 83% on liquidity, 80% on profitability and 95% on growth.

The bankruptcy probability was computed on 22-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 4.24, cash €62,986
NBB · annual accounts
lowers risk · Equity €81,135 (82.6% of total assets)
NBB · annual accounts
lowers risk · Size: total assets €98,168
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
raises risk · Young company
Founded in 2025, a year ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 1 year 0 10 years
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2026 was due by 31-01-2027 and was filed on 14-09-2026, 139 days ahead of the deadline.
NBB · 2 filings
Deviation from the deadline
2026
139 days early
2025
23 days early
← before the deadline after the deadline →
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 30-06-2027 and is due by 31-01-2028. Nothing is late today.
Companies Code · seven months
Where today falls in the filing period
23-10-2026 today30-06-2027 year end31-01-2028 deadline
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2025.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2026 · micro…
  2. Liquidity more than quadruplescurrent ratio 4.24
  3. Annual accounts filedfinancial year 2025 · micro…

Key points

  • Positive: Equity rose in 2026from €28,555 to €81,135 ▲ 184% View
  • Founded 17 months agofounded 08-05-2025 17 months View
  • One director decidessole director in office 1 View

By topic

Financials

Financial year
2026
Total assets
€98,168
Profit
€53,413
Solvency
82.6%
Total assets▲ 135%
Net result
20252026
Go to Financials

Timeline

Events
4
Since
2025
Next accounts
by 31-01-2028
  1. 12-05-2025Incorporation
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Specialist medical practiceNACE 86220
Founded
08-05-2025
Year ends
30-06
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.